UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 399

Sortiert nach

Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation

Journal of clinical oncology, 2012-09, Vol.30 (26), p.3202-3208

2012

Volltextzugriff (PDF)

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Journal of clinical oncology, 2017-04, Vol.35 (11), p.1154-1161

2017

Volltextzugriff (PDF)

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

Blood, 2014-06, Vol.123 (23), p.3664-3671

2014

Volltextzugriff (PDF)

Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease

Blood, 2016-07, Vol.128 (1), p.130-137

2016

Volltextzugriff (PDF)

A disease risk index for patients undergoing allogeneic stem cell transplantation

Blood, 2012-07, Vol.120 (4), p.905-913

2012

Volltextzugriff (PDF)

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

The New England journal of medicine, 2011-12, Vol.365 (22), p.2055-2066

2011

Volltextzugriff (PDF)

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

Blood, 2007-05, Vol.109 (10), p.4586-4588

2007

Volltextzugriff (PDF)

Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation

Haematologica (Roma), 2016-04, Vol.101 (4), p.499

2016

Volltextzugriff (PDF)

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease

Blood, 2009-04, Vol.113 (16), p.3865-3874

2009

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation outcomes in patients with Richter's transformation

Haematologica (Roma), 2021-12, Vol.106 (12), p.3219

2021

Volltextzugriff (PDF)

High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML

Blood, 2018-06, Vol.131 (25), p.2816-2825

2018

Volltextzugriff (PDF)

Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results

Haematologica (Roma), 2018-03, Vol.103 (3), p.522

2018

Volltextzugriff (PDF)

Maximizing GVL in allogeneic transplantation: role of donor lymphocyte infusions

Hematology, 2014-12, Vol.2014 (1), p.570-575

2014

Volltextzugriff (PDF)

A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation

Haematologica (Roma), 2016-10, Vol.101 (10), p.1251

2016

Volltextzugriff (PDF)

Venous thromboembolism is associated with graft- versus -host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation

Haematologica (Roma), 2017-07, Vol.102 (7), p.1185

2017

Volltextzugriff (PDF)

Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors

Blood, 2009-10, Vol.114 (18), p.3956-3959

2009

Volltextzugriff (PDF)

The addition of sirolimus to the graft‐versus‐host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial

British journal of haematology, 2016-04, Vol.173 (1), p.96-104

2016

Volltextzugriff (PDF)

Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion

Blood, 2014-02, Vol.123 (9), p.1412-1421

2014

Volltextzugriff (PDF)

Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease

Blood, 2011-02, Vol.117 (7), p.2275-2283

2011

Volltextzugriff (PDF)

Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy

Cell reports (Cambridge), 2023-08, Vol.42 (8), p.113011-113011, Article 113011

2023

Volltextzugriff (PDF)

Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation

Journal of clinical oncology, 2009-10, Vol.27 (30), p.e147-e149

2009

Volltextzugriff (PDF)

Low-dose IL-2 selectively activates subsets of CD4 + Tregs and NK cells

JCI insight, 2016-11, Vol.1 (18), p.e89278-e89278

2016

Volltextzugriff (PDF)

Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantation

Oral surgery, oral medicine, oral pathology and oral radiology, 2017-09, Vol.124 (3), p.253-260

2017

Volltextzugriff (PDF)

1 – 25 von 399

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(281)
Mit Volltextzugriff
(377)

Publikationsform

Sprache

Englisch
(399)
Japanisch
(56)

Erscheinungsjahr

n.n

Thema

Science & Technology
(200)
Life Sciences & Biomedicine
(198)
Humans
(194)
Hematology
(146)
Male
(146)
Middle Aged
(141)
Female
(137)
Adult
(131)
Transplantation
(104)
Aged
(95)
Transplantation, Homologous
(80)
Immunology
(74)
Hematology, Oncology And Palliative Medicine
(66)
Biological And Medical Sciences
(59)
Medical Sciences
(59)
Treatment Outcome
(53)
Hematopoietic Stem Cell Transplantation
(47)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(47)
Retrospective Studies
(47)
Young Adult
(43)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease

A disease risk index for patients undergoing allogeneic stem cell transplantation

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease

Allogeneic hematopoietic cell transplantation outcomes in patients with Richter's transformation

High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML

Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results

Maximizing GVL in allogeneic transplantation: role of donor lymphocyte infusions

A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation

Venous thromboembolism is associated with graft- versus -host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation

Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors

The addition of sirolimus to the graft‐versus‐host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial

Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion

Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease

Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy

Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation

Low-dose IL-2 selectively activates subsets of CD4 + Tregs and NK cells

Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease

Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantation

Suchergebnisse filtern